"Frank breaks down how the crop protection business has shifted from mostly on-patent products to a world dominated by off-patent actives, and why the next decade of innovation might be less about brand-new molecules and more about formulation, mixtures, and better fit-for-purpose tools."
"What's actually happening with biologicals (and the difference between yield promise and real-world ROI), how resistance management is driving adoption in places like Brazil, and why regulatory speed matters when you're trying to commercialize anything new are all questions they dig into."
"They connect dots between ag, health, defence, and AI, and why Canada has a real window right now to attract talent, build commercialization capacity, and expand export opportunities."
UPL CEO Mike Frank discusses the evolving crop protection industry, highlighting the transition from patent-protected products to off-patent actives. Innovation priorities are shifting toward formulation improvements, mixture development, and fit-for-purpose solutions rather than entirely new molecules. The conversation addresses biologicals' real-world return on investment versus yield promises, resistance management adoption in markets like Brazil, and regulatory speed's importance for commercialization. Connections are drawn between agriculture, health, defense, and artificial intelligence sectors. Canada's competitive advantages are explored, including opportunities to attract talent, build commercialization capacity, and expand export markets within the current market window.
#crop-protection-innovation #off-patent-actives #biologicals-and-roi #resistance-management #canada-agricultural-opportunity
Read at Realagriculture
Unable to calculate read time
Collection
[
|
...
]